Merck & Company Inc, Common Stock






Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
Volume info-icon
This is the total number of shares traded during the most recent trading day.
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$98.43 L
$130.24 H

About Merck & Company Inc, Common Stock

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, im...more

Industry: PharmaceuticalsSector: Health Care


Time FrameMRKSectorS&P500
1-Week Return-1.92%-2.06%0.03%
1-Month Return0.46%1.84%3.84%
3-Month Return23.6%10.35%11.14%
6-Month Return17.22%9.35%13.49%
1-Year Return22.37%15.97%30.78%
3-Year Return102.13%33%36.58%
5-Year Return89.9%69.86%97.17%
10-Year Return220.88%188.37%231.4%


Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue46.84B47.99B48.70B59.28B60.12B[{"date":"2019-12-31","value":77.92,"profit":true},{"date":"2020-12-31","value":79.84,"profit":true},{"date":"2021-12-31","value":81.02,"profit":true},{"date":"2022-12-31","value":98.62,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue14.11B15.48B13.63B17.41B13.90B[{"date":"2019-12-31","value":81.05,"profit":true},{"date":"2020-12-31","value":88.94,"profit":true},{"date":"2021-12-31","value":78.26,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.82,"profit":true}]
Gross Profit32.73B32.51B35.08B41.87B46.22B[{"date":"2019-12-31","value":70.81,"profit":true},{"date":"2020-12-31","value":70.34,"profit":true},{"date":"2021-12-31","value":75.9,"profit":true},{"date":"2022-12-31","value":90.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin69.87%67.74%72.02%70.63%76.88%[{"date":"2019-12-31","value":90.88,"profit":true},{"date":"2020-12-31","value":88.1,"profit":true},{"date":"2021-12-31","value":93.68,"profit":true},{"date":"2022-12-31","value":91.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses20.49B24.03B21.88B23.59B40.01B[{"date":"2019-12-31","value":51.21,"profit":true},{"date":"2020-12-31","value":60.05,"profit":true},{"date":"2021-12-31","value":54.69,"profit":true},{"date":"2022-12-31","value":58.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income9.23B5.44B10.65B14.71B6.21B[{"date":"2019-12-31","value":62.73,"profit":true},{"date":"2020-12-31","value":36.95,"profit":true},{"date":"2021-12-31","value":72.37,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":42.22,"profit":true}]
Total Non-Operating Income/Expense1.62B2.58B2.46B929.00M(5.00B)[{"date":"2019-12-31","value":62.64,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":95.35,"profit":true},{"date":"2022-12-31","value":35.97,"profit":true},{"date":"2023-12-31","value":-193.69,"profit":false}]
Pre-Tax Income11.46B8.79B13.88B16.44B1.89B[{"date":"2019-12-31","value":69.72,"profit":true},{"date":"2020-12-31","value":53.46,"profit":true},{"date":"2021-12-31","value":84.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":11.49,"profit":true}]
Income Taxes1.69B1.71B1.52B1.92B1.51B[{"date":"2019-12-31","value":87.96,"profit":true},{"date":"2020-12-31","value":89.1,"profit":true},{"date":"2021-12-31","value":79.3,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":78.83,"profit":true}]
Income After Taxes9.78B7.08B12.36B14.53B377.00M[{"date":"2019-12-31","value":67.31,"profit":true},{"date":"2020-12-31","value":48.75,"profit":true},{"date":"2021-12-31","value":85.08,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.6,"profit":true}]
Income From Continuous Operations9.78B7.08B12.36B14.53B4.62B[{"date":"2019-12-31","value":67.31,"profit":true},{"date":"2020-12-31","value":48.75,"profit":true},{"date":"2021-12-31","value":85.08,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":31.81,"profit":true}]
Income From Discontinued Operations704.00M704.00M704.00M--[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income9.84B7.07B13.05B14.52B365.00M[{"date":"2019-12-31","value":67.79,"profit":true},{"date":"2020-12-31","value":48.67,"profit":true},{"date":"2021-12-31","value":89.88,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.51,"profit":true}]
EPS (Diluted)5.195.936.267.481.50[{"date":"2019-12-31","value":69.39,"profit":true},{"date":"2020-12-31","value":79.28,"profit":true},{"date":"2021-12-31","value":83.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":20.05,"profit":true}]



These ratios help you determine the liquidity of the company. Higher is better.

Cash Ratio 0.34
Current Ratio 0.34
Quick Ratio 0.09

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ROA (LTM) 2.64%
ROE (LTM) 0.90%


These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

Debt Ratio Lower is generally better. Negative is bad. 0.65
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.39
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. 2.84


These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

Trailing PE 908.21
Forward PE 14.86
P/S (TTM) 5.36
P/B 8.57
Price/FCF NM
EV/R 5.82
EV/Ebitda 50.67


Top pharma group Merck opens regional office in Riyadh

Merck, a leading company in the fields of science, technology, and medicine, has inaugurated a new regional office in the Kingdom of Saudi Arabia. Riyadh will thus be the regional office for the Middle East and North Africa, and a leading hub for …

4 Mar, 2024 a 12:23 am EIN News Pharmaceuticals

5 Best Large-Cap Value Stocks To Invest In in 2024

In this piece, we will take a look at the five best large cap value stocks to invest in in 2024. If you want to learn more about large cap stocks and their fluctuations, then read 16 Best Large-Cap Value Stocks To Invest In in 2024. 5. Merck & Co., Inc. (NYSE:MRK) Number of Hedge […]

2 Mar, 2024 a 3:42 pm Insider Monkey

Senators grilled Big Pharma CEOs Joaquin Duato, Robert Davis, and Chris Boerner on Drug Pricing

During a Senate committee hearing on Thursday, the CEOs of three big drugmakers faced sharp criticism from lawmakers over the exorbitant cost of prescription drugs in the United States. Senators heard testimony from Joaquin Duato of Johnson & Johnson, Robert M. Davis of Merck, and Christopher Boerner of Bristol Myers Squibb. The hearing was held […] The post Senators grilled Big Pharma CEOs Joaquin Duato, Robert Davis, and Chris Boerner on Drug Pricing appeared first on CEOWORLD magazine . Copyright CEOWORLD magazine 2023.

2 Mar, 2024 a 3:43 am CEOWORLD magazine

Merck opens new EUR 20 million distribution center in Brazil

Merck ’s Life Science divisions has … Distribution for Life Science at Merck , in Brazil, the move to … hours. "In 2023, the pharmaceutical industry and academic markets in … site is closely alignment with Merck ’s global sustainability objectives. The …

1 Mar, 2024 a 4:32 pm EIN News Pharmaceuticals


What is Merck & Company Inc share price today?

Merck & Company Inc (MRK) share price today is $126.96

Can Indians buy Merck & Company Inc shares?

Yes, Indians can buy shares of Merck & Company Inc (MRK) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MRK stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Merck & Company Inc be purchased?

Yes, you can purchase fractional shares of Merck & Company Inc (MRK) via the Vested app. You can start investing in Merck & Company Inc (MRK) with a minimum investment of $1.

How to invest in Merck & Company Inc shares from India?

You can invest in shares of Merck & Company Inc (MRK) via Vested in three simple steps:

  • Click on Sign Up or Invest in MRK stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Merck & Company Inc shares
What is Merck & Company Inc 52-week high and low stock price?

The 52-week high price of Merck & Company Inc (MRK) is 130.24. The 52-week low price of Merck & Company Inc (MRK) is 98.43.

What is Merck & Company Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Merck & Company Inc (MRK) is 886.18

What is Merck & Company Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Merck & Company Inc (MRK) is 8.57

What is Merck & Company Inc dividend yield?

The dividend yield of Merck & Company Inc (MRK) is 2.42%

What is the Market Cap of Merck & Company Inc?

The market capitalization of Merck & Company Inc (MRK) is $321.62B

What is Merck & Company Inc’s stock symbol?

The stock symbol (or ticker) of Merck & Company Inc is MRK

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top